PL353366A1 - Pirozolo[4,3-d]pirymidyny - Google Patents

Pirozolo[4,3-d]pirymidyny

Info

Publication number
PL353366A1
PL353366A1 PL00353366A PL35336600A PL353366A1 PL 353366 A1 PL353366 A1 PL 353366A1 PL 00353366 A PL00353366 A PL 00353366A PL 35336600 A PL35336600 A PL 35336600A PL 353366 A1 PL353366 A1 PL 353366A1
Authority
PL
Poland
Prior art keywords
pyrazolo
pyrimidines
Prior art date
Application number
PL00353366A
Other languages
English (en)
Inventor
Rochus Jonas
Hans-Michael Eggenweiler
Pierre Schelling
Maria Christadler
Norbert Beier
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL353366A1 publication Critical patent/PL353366A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL00353366A 1999-09-06 2000-08-24 Pirozolo[4,3-d]pirymidyny PL353366A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19942474A DE19942474A1 (de) 1999-09-06 1999-09-06 Pyrazolo[4,3-d]pyrimidine
PCT/EP2000/008257 WO2001018004A2 (de) 1999-09-06 2000-08-24 PYRAZOLO[4,3-d]PYRIMIDINE

Publications (1)

Publication Number Publication Date
PL353366A1 true PL353366A1 (pl) 2003-11-17

Family

ID=7920966

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00353366A PL353366A1 (pl) 1999-09-06 2000-08-24 Pirozolo[4,3-d]pirymidyny

Country Status (23)

Country Link
US (1) US6777419B1 (pl)
EP (1) EP1210349B1 (pl)
JP (1) JP4975921B2 (pl)
KR (1) KR20020025253A (pl)
CN (1) CN1145627C (pl)
AR (1) AR025569A1 (pl)
AT (1) ATE231866T1 (pl)
AU (1) AU773878B2 (pl)
BR (1) BR0013781A (pl)
CA (1) CA2384037C (pl)
CZ (1) CZ294587B6 (pl)
DE (2) DE19942474A1 (pl)
DK (1) DK1210349T3 (pl)
ES (1) ES2189766T3 (pl)
HU (1) HUP0202624A3 (pl)
MX (1) MXPA02002383A (pl)
NO (1) NO20021083D0 (pl)
PL (1) PL353366A1 (pl)
PT (1) PT1210349E (pl)
RU (1) RU2249594C2 (pl)
SK (1) SK3132002A3 (pl)
WO (1) WO2001018004A2 (pl)
ZA (1) ZA200202653B (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10031584A1 (de) 2000-06-29 2002-01-10 Merck Patent Gmbh 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine
DE10058662A1 (de) * 2000-11-25 2002-05-29 Merck Patent Gmbh Verwendung von Pyrazolo[4,3-d]pyrimidinen
BR0115995A (pt) * 2000-12-19 2004-01-13 Merck Patent Gmbh Formulação farmacêutica compreendendo pirazolo[4,3-d]pirimidinas e antitrombóticos, antagonistas de cálcio, prostaglandinas ou derivados de prostaglandina
DE10103647A1 (de) 2001-01-27 2002-08-01 Merck Patent Gmbh Verfahren zur Herstellung eines Pyrazolo (4,3-d) pyrimidinderivates
DE10148883A1 (de) * 2001-10-04 2003-04-10 Merck Patent Gmbh Pyrimidinderivate
KR100824193B1 (ko) 2003-04-29 2008-04-21 화이자 인코포레이티드 고혈압 치료에 유용한5,7-디아미노피라졸로[4,3-ｄ]피리미딘
GB0327323D0 (en) * 2003-11-24 2003-12-31 Pfizer Ltd Novel pharmaceuticals
US7572799B2 (en) * 2003-11-24 2009-08-11 Pfizer Inc Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
JP2007532526A (ja) * 2004-04-07 2007-11-15 ファイザー・インク ピラゾロ［４，３−ｄ］ピリミジン類
PT1881985E (pt) 2005-05-12 2011-02-01 Pfizer Formas cristalinas anidras de n-[1-(2-etoxietil)-5-(n- -etil-n-metilamino)-7-(4-metilpiridin-2-il-amino)-1h- -pirazolo[4,3-d]pirimidino-3-carbonil]metanossulfonamida
NL2000291C2 (nl) 2005-11-10 2009-02-17 Pfizer Prod Inc 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H- pyrazool(4,3-d)pyrimidine-5-yl)piperidine-4-carbonzuur en zouten daarvan.
AU2012244550C1 (en) * 2011-04-21 2017-06-22 Origenis Gmbh Pyrazolo [4, 3-d] pyrimidines useful as kinase inhibitors
CZ308056B6 (cs) * 2015-07-20 2019-11-27 Ustav Experimentalni Botaniky Av Cr V V I 5-Substituované-7-[4-(substituované)benzyl]amino-3-isopropylpyrazolo[4,3-d]pyrimidiny, jejich použití jako antirevmatika, a farmaceutické přípravky
US10034861B2 (en) * 2016-07-04 2018-07-31 H. Lundbeck A/S 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
RU2020118913A (ru) * 2017-12-14 2022-01-14 Х. Лундбекк А/С (H. Lundbeck A/S) Виды комбинированного лечения, предусматривающего введение 1h-пиразолo[4,3-b]пиридинов
AR113926A1 (es) 2017-12-14 2020-07-01 H Lundbeck As Derivados de 1h-pirazolo[4,3-b]piridinas
US11535611B2 (en) 2017-12-20 2022-12-27 H. Lundbeck A/S Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitors
US10766893B2 (en) * 2017-12-20 2020-09-08 H. Lundbeck A/S 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256650A (en) * 1989-03-29 1993-10-26 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
GB9114760D0 (en) * 1991-07-09 1991-08-28 Pfizer Ltd Therapeutic agents
DE19644228A1 (de) * 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine
CA2288910C (en) * 1997-04-25 2003-06-24 Pfizer Inc. Pyrazolopyrimidinones for sexual dysfunction
DE19752952A1 (de) * 1997-11-28 1999-06-02 Merck Patent Gmbh Thienopyrimidine
DE10031584A1 (de) * 2000-06-29 2002-01-10 Merck Patent Gmbh 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine
DE10058662A1 (de) * 2000-11-25 2002-05-29 Merck Patent Gmbh Verwendung von Pyrazolo[4,3-d]pyrimidinen
DE10060388A1 (de) * 2000-12-05 2002-06-06 Merck Patent Gmbh Verwendung von Pyrazolo [4,3-d]pyrimidinen
DE10103647A1 (de) * 2001-01-27 2002-08-01 Merck Patent Gmbh Verfahren zur Herstellung eines Pyrazolo (4,3-d) pyrimidinderivates

Also Published As

Publication number Publication date
CA2384037C (en) 2009-10-13
DE19942474A1 (de) 2001-03-15
DK1210349T3 (da) 2003-05-19
CA2384037A1 (en) 2001-03-15
NO20021083L (no) 2002-03-05
EP1210349B1 (de) 2003-01-29
AU7279300A (en) 2001-04-10
NO20021083D0 (no) 2002-03-05
CN1145627C (zh) 2004-04-14
KR20020025253A (ko) 2002-04-03
HUP0202624A2 (hu) 2002-12-28
RU2249594C2 (ru) 2005-04-10
PT1210349E (pt) 2003-06-30
WO2001018004A3 (de) 2001-08-09
DE50001191D1 (de) 2003-03-06
ZA200202653B (en) 2003-09-23
ES2189766T3 (es) 2003-07-16
SK3132002A3 (en) 2002-07-02
WO2001018004A2 (de) 2001-03-15
HUP0202624A3 (en) 2004-11-29
CN1377357A (zh) 2002-10-30
CZ2002736A3 (cs) 2002-05-15
MXPA02002383A (es) 2002-09-02
AU773878B2 (en) 2004-06-10
EP1210349A2 (de) 2002-06-05
BR0013781A (pt) 2002-05-14
AR025569A1 (es) 2002-12-04
CZ294587B6 (cs) 2005-02-16
JP4975921B2 (ja) 2012-07-11
ATE231866T1 (de) 2003-02-15
JP2003508534A (ja) 2003-03-04
US6777419B1 (en) 2004-08-17

Similar Documents

Publication Publication Date Title
EG24399A (en) Pyrrolo[2,3-D]pyrimidine compounds
IL149026A0 (en) PYRAZOLO [4, 3-d] PYRIMIDINE DERIVATIVES
IL139598A0 (en) PYRROLO [2,3-d] PYRIMIDINE COMPOUNDS
IL139586A0 (en) PYRROLO [2,3-d] PYRIMIDINE COMPOUNDS
EP0923287A4 (en) NON-CLASSIC PYRROLO (2,3-D) PYRIMIDINE ANTIFOLATE
DK1210349T3 (da) Pyrazolo[4,3-d]pyrimidiner
PL358551A1 (pl) 5-Aminoalkilopirazolo [4,3-D] pirymidyny
MXPA03004498A (es) Uso de pirazolo (4,3-d)pirimidinas.
MXPA03004907A (es) Uso de pirazolo (4,3-d) pirimidinas.
IL131892A0 (en) 6, 7-Disubstituted-4-aminopyrido [2, 3-d] pyrimidine compounds
PL336265A1 (en) 5,6,7-trisubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
AU2001285785A1 (en) 2-aminoalkyl-thieno[2,3-d]pyrimidines
IL155380A0 (en) SUBSTITUTED 3,4-DIHYDRO-PYRIDO[1,2-a] PYRIMIDINES
SI1210349T1 (en) PYRAZOLO 4,3-d)PYRIMIDINES
ZA200202763B (en) Pyrazolo [4,3-D] pyrimidine derivatives.
ZA994004B (en) Pyrrolo[2,3-d]pyrimidine compounds.
SI1087970T1 (en) PYRROLO 2,3-d)PYRIMIDINE COMPOUNDS

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)